Two new studies further question Avandia safety
September 12 2007
Two new studies have once again called into question the safety of GlaxoSmithKlines type 2 diabetes drug Avandia.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.